Skip to main content
Top
Published in: BMC Medicine 1/2024

Open Access 01-12-2024 | Post-COVID Syndrome | Research article

Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID)

Authors: Ekaterina Pazukhina, Mikhail Rumyantsev, Dina Baimukhambetova, Elena Bondarenko, Nadezhda Markina, Yasmin El-Taravi, Polina Petrova, Anastasia Ezhova, Margarita Andreeva, Ekaterina Iakovleva, Polina Bobkova, Maria Pikuza, Anastasia Trefilova, Elina Abdeeva, Aysylu Galiautdinova, Yulia Filippova, Anastasiia Bairashevskaia, Aleksandr Zolotarev, Nikolay Bulanov, Audrey DunnGalvin, Anastasia Chernyavskaya, Elena Kondrikova, Anastasia Kolotilina, Svetlana Gadetskaya, Yulia V. Ivanova, Irina Turina, Alina Eremeeva, Ludmila A. Fedorova, Pasquale Comberiati, Diego G. Peroni, Nikita Nekliudov, Jon Genuneit, Luis Felipe Reyes, Caroline L. H. Brackel, Lyudmila Mazankova, Alexandra Miroshina, Elmira Samitova, Svetlana Borzakova, Gail Carson, Louise Sigfrid, Janet T. Scott, Sammie McFarland, Matthew Greenhawt, Danilo Buonsenso, Malcolm G. Semple, John O. Warner, Piero Olliaro, Ismail M. Osmanov, Anatoliy A. Korsunskiy, Daniel Munblit, Sechenov StopCOVID Research Team

Published in: BMC Medicine | Issue 1/2024

Login to get access

Abstract

Background

Long-term health outcomes in children and young people (CYP) after COVID-19 infection are not well understood and studies with control groups exposed to other infections are lacking. This study aimed to investigate the incidence of post-COVID-19 condition (PCC) and incomplete recovery in CYP after hospital discharge and compare outcomes between different SARS-CoV-2 variants and non-SARS-CoV-2 infections.

Methods

A prospective exposure-stratified cohort study of individuals under 18 years old in Moscow, Russia. Exposed cohorts were paediatric patients admitted with laboratory-confirmed COVID-19 infection between April 2 and December 11, 2020 (Wuhan variant cohort) and between January 12 and February 19, 2022 (Omicron variant cohort). CYP admitted with respiratory and intestinal infections, but negative lateral flow rapid diagnostic test and PCR-test results for SARS-CoV-2, between January 12 and February 19, 2022, served as unexposed reference cohort. Comparison between the ‘exposed cohorts’ and ‘reference cohort’ was conducted using 1:1 matching by age and sex. Follow-up data were collected via telephone interviews with parents, utilising the long COVID paediatric protocol and survey developed by the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). The WHO case definition was used to categorise PCC.

Results

Of 2595 CYP with confirmed COVID-19, 1707 (65.7%) participated in follow-up interviews, with 1183/1707 (69%) included in the final ‘matched’ analysis. The median follow-up time post-discharge was 6.7 months. The incidence of PCC was significantly higher in the Wuhan variant cohort (89.7 cases per 1000 person-months, 95% CI 64.3–120.3) compared to post-infection sequalae in the reference cohort (12.2 cases per 1000 person-months, 95% CI 4.9–21.9), whereas the difference with the Omicron variant cohort and reference cohort was not significant. The Wuhan cohort had higher incidence rates of dermatological, fatigue, gastrointestinal, sensory, and sleep manifestations, as well as behavioural and emotional problems than the reference cohort. The only significant difference between Omicron variant cohort and reference cohort was decreased school attendance. When comparing the Wuhan and Omicron variant cohorts, higher incidence of PCC and event rates of fatigue, decreased physical activity, and deterioration of relationships was observed. The rate of incomplete recovery was also significantly higher in the Wuhan variant cohort than in both the reference and the Omicron variant cohorts.

Conclusions

Wuhan variant exhibited a propensity for inducing a broad spectrum of physical symptoms and emotional behavioural changes, suggesting a pronounced impact on long-term health outcomes. Conversely, the Omicron variant resulted in fewer post-infection effects no different from common seasonal viral illnesses. This may mean that the Omicron variant and subsequent variants might not lead to the same level of long-term health consequences as earlier variants.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950.ADSCrossRefPubMedPubMedCentral Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950.ADSCrossRefPubMedPubMedCentral
3.
go back to reference Berg SK, Palm P. Playing catch with long COVID - understanding a new disease. Lancet Reg Health Eur. 2023;25:100568.CrossRefPubMed Berg SK, Palm P. Playing catch with long COVID - understanding a new disease. Lancet Reg Health Eur. 2023;25:100568.CrossRefPubMed
5.
go back to reference Pinto Pereira SM, Shafran R, Nugawela MD, Panagi L, Hargreaves D, Ladhani SN, Bennett SD, Chalder T, Dalrymple E, Ford T, et al. Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months. Lancet Reg Health Eur. 2023;25:100554.CrossRefPubMed Pinto Pereira SM, Shafran R, Nugawela MD, Panagi L, Hargreaves D, Ladhani SN, Bennett SD, Chalder T, Dalrymple E, Ford T, et al. Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months. Lancet Reg Health Eur. 2023;25:100554.CrossRefPubMed
6.
go back to reference Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022;181(4):1597–607.CrossRefPubMedPubMedCentral Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022;181(4):1597–607.CrossRefPubMedPubMedCentral
7.
go back to reference Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, Murray B, Klaser K, Kerfoot E, Chen L, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5(10):708–18.CrossRefPubMedPubMedCentral Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, Murray B, Klaser K, Kerfoot E, Chen L, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5(10):708–18.CrossRefPubMedPubMedCentral
8.
9.
go back to reference Fink TT, Marques HHS, Gualano B, Lindoso L, Bain V, Astley C, Martins F, Matheus D, Matsuo OM, Suguita P, et al. Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: a prospective study in a Latin American tertiary hospital. Clinics (Sao Paulo). 2021;76:e3511.CrossRefPubMed Fink TT, Marques HHS, Gualano B, Lindoso L, Bain V, Astley C, Martins F, Matheus D, Matsuo OM, Suguita P, et al. Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: a prospective study in a Latin American tertiary hospital. Clinics (Sao Paulo). 2021;76:e3511.CrossRefPubMed
10.
go back to reference Roessler M, Tesch F, Batram M, Jacob J, Loser F, Weidinger O, Wende D, Vivirito A, Toepfner N, Ehm F, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19(11):e1004122.CrossRefPubMedPubMedCentral Roessler M, Tesch F, Batram M, Jacob J, Loser F, Weidinger O, Wende D, Vivirito A, Toepfner N, Ehm F, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19(11):e1004122.CrossRefPubMedPubMedCentral
11.
go back to reference Munblit D, Nicholson TR, Needham DM, Seylanova N, Parr C, Chen J, Kokorina A, Sigfrid L, Buonsenso D, Bhatnagar S, et al. Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development. BMC Med. 2022;20(1):50.CrossRefPubMedPubMedCentral Munblit D, Nicholson TR, Needham DM, Seylanova N, Parr C, Chen J, Kokorina A, Sigfrid L, Buonsenso D, Bhatnagar S, et al. Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development. BMC Med. 2022;20(1):50.CrossRefPubMedPubMedCentral
12.
go back to reference Munblit D, Sigfrid L, Warner JO. Setting priorities to address research gaps in long-term COVID-19 outcomes in children. JAMA Pediatr. 2021;175:1095–6.CrossRefPubMed Munblit D, Sigfrid L, Warner JO. Setting priorities to address research gaps in long-term COVID-19 outcomes in children. JAMA Pediatr. 2021;175:1095–6.CrossRefPubMed
13.
go back to reference Roge I, Smane L, Kivite-Urtane A, Pucuka Z, Racko I, Klavina L, Pavare J. Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Front Pediatr. 2021;9:752385.CrossRefPubMedPubMedCentral Roge I, Smane L, Kivite-Urtane A, Pucuka Z, Racko I, Klavina L, Pavare J. Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Front Pediatr. 2021;9:752385.CrossRefPubMedPubMedCentral
14.
go back to reference Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355–68.CrossRefPubMedPubMedCentral Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355–68.CrossRefPubMedPubMedCentral
15.
go back to reference Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of long COVID-19 caused by different SARS-CoV-2 Strains: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(23):16010.CrossRefPubMedPubMedCentral Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of long COVID-19 caused by different SARS-CoV-2 Strains: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(23):16010.CrossRefPubMedPubMedCentral
16.
go back to reference Chaichana U, Man KKC, Chen A, Wong ICK, George J, Wilson P, Wei L. Definition of post-COVID-19 condition among published research studies. JAMA Netw Open. 2023;6(4):e235856.CrossRefPubMedPubMedCentral Chaichana U, Man KKC, Chen A, Wong ICK, George J, Wilson P, Wei L. Definition of post-COVID-19 condition among published research studies. JAMA Netw Open. 2023;6(4):e235856.CrossRefPubMedPubMedCentral
17.
go back to reference Gushchin VA, Pochtovyi AA, Kustova DD, Ogarkova DA, Tarnovetskii IY, Belyaeva ED, Divisenko EV, Vasilchenko LA, Shidlovskaya EV, Kuznetsova NA, et al. Dynamics of SARS-CoV-2 major genetic lineages in moscow in the context of vaccine prophylaxis. Int J Mol Sci. 2022;23(23):14670.CrossRefPubMedPubMedCentral Gushchin VA, Pochtovyi AA, Kustova DD, Ogarkova DA, Tarnovetskii IY, Belyaeva ED, Divisenko EV, Vasilchenko LA, Shidlovskaya EV, Kuznetsova NA, et al. Dynamics of SARS-CoV-2 major genetic lineages in moscow in the context of vaccine prophylaxis. Int J Mol Sci. 2022;23(23):14670.CrossRefPubMedPubMedCentral
18.
go back to reference Munblit D, Nekliudov NA, Bugaeva P, Blyuss O, Kislova M, Listovskaya E, Gamirova A, Shikhaleva A, Belyaev V, Timashev P, et al. Stop COVID cohort: an observational study of 3480 patients admitted to the Sechenov University Hospital Network in Moscow City for suspected coronavirus disease 2019 (COVID-19) infection. Clin Infect Dis. 2021;73(1):1–11.CrossRefPubMed Munblit D, Nekliudov NA, Bugaeva P, Blyuss O, Kislova M, Listovskaya E, Gamirova A, Shikhaleva A, Belyaev V, Timashev P, et al. Stop COVID cohort: an observational study of 3480 patients admitted to the Sechenov University Hospital Network in Moscow City for suspected coronavirus disease 2019 (COVID-19) infection. Clin Infect Dis. 2021;73(1):1–11.CrossRefPubMed
19.
go back to reference Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, Blyuss O, El-Taravi Y, DunnGalvin A, Comberiati P, Peroni DG, Apfelbacher C, Genuneit J, Mazankova L, Miroshina A, Chistyakova E, Samitova E, Borzakova S, Bondarenko E, Korsunskiy AA, Konova I, Hanson SW, Carson G, Sigfrid L, Scott JT, Greenhawt M, Whittaker EA, Garralda E, Swann OV, Buonsenso D, Nicholls DE, Simpson F, Jones C, Semple MG, Warner JO, Vos T, Olliaro P, Munblit D; and the Sechenov StopCOVID Research Team. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59(2):2101341. https://doi.org/10.1183/13993003.01341-2021. Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, Blyuss O, El-Taravi Y, DunnGalvin A, Comberiati P, Peroni DG, Apfelbacher C, Genuneit J, Mazankova L, Miroshina A, Chistyakova E, Samitova E, Borzakova S, Bondarenko E, Korsunskiy AA, Konova I, Hanson SW, Carson G, Sigfrid L, Scott JT, Greenhawt M, Whittaker EA, Garralda E, Swann OV, Buonsenso D, Nicholls DE, Simpson F, Jones C, Semple MG, Warner JO, Vos T, Olliaro P, Munblit D; and the Sechenov StopCOVID Research Team. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59(2):2101341. https://​doi.​org/​10.​1183/​13993003.​01341-2021.
20.
go back to reference Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, Rumyantsev M, Gamirova A, Bairashevskaia A, Petrova P, et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. 2022;20(1):244.CrossRefPubMedPubMedCentral Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, Rumyantsev M, Gamirova A, Bairashevskaia A, Petrova P, et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. 2022;20(1):244.CrossRefPubMedPubMedCentral
21.
go back to reference Pellegrino R, Chiappini E, Licari A, Galli L, Marseglia GL. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181(12):3995–4009.CrossRefPubMedPubMedCentral Pellegrino R, Chiappini E, Licari A, Galli L, Marseglia GL. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181(12):3995–4009.CrossRefPubMedPubMedCentral
23.
go back to reference Mittal A, Khattri A, Verma V. Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants. PLoS Pathog. 2022;18(2):e1010260.CrossRefPubMedPubMedCentral Mittal A, Khattri A, Verma V. Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants. PLoS Pathog. 2022;18(2):e1010260.CrossRefPubMedPubMedCentral
Metadata
Title
Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID)
Authors
Ekaterina Pazukhina
Mikhail Rumyantsev
Dina Baimukhambetova
Elena Bondarenko
Nadezhda Markina
Yasmin El-Taravi
Polina Petrova
Anastasia Ezhova
Margarita Andreeva
Ekaterina Iakovleva
Polina Bobkova
Maria Pikuza
Anastasia Trefilova
Elina Abdeeva
Aysylu Galiautdinova
Yulia Filippova
Anastasiia Bairashevskaia
Aleksandr Zolotarev
Nikolay Bulanov
Audrey DunnGalvin
Anastasia Chernyavskaya
Elena Kondrikova
Anastasia Kolotilina
Svetlana Gadetskaya
Yulia V. Ivanova
Irina Turina
Alina Eremeeva
Ludmila A. Fedorova
Pasquale Comberiati
Diego G. Peroni
Nikita Nekliudov
Jon Genuneit
Luis Felipe Reyes
Caroline L. H. Brackel
Lyudmila Mazankova
Alexandra Miroshina
Elmira Samitova
Svetlana Borzakova
Gail Carson
Louise Sigfrid
Janet T. Scott
Sammie McFarland
Matthew Greenhawt
Danilo Buonsenso
Malcolm G. Semple
John O. Warner
Piero Olliaro
Ismail M. Osmanov
Anatoliy A. Korsunskiy
Daniel Munblit
Sechenov StopCOVID Research Team
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2024
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-023-03221-x

Other articles of this Issue 1/2024

BMC Medicine 1/2024 Go to the issue